Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16
Clinical trial NCT03164967 · COMPLETED
Trial details
- NCT number
- NCT03164967
- Sponsor
- ADMA Biologics, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-29
- Primary completion
- 2022-08-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.